Buy Stocks Easy | About Us
March 30, 2020
Buy Stocks Easy | Online Stocks

MGNX


Buy MacroGenics, Inc. Stock (symbol: MGNX) Easy Online

Company Name: MacroGenics, Inc.

Symbol: MGNX

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2013

MGNX Current Share Price

Today's MGNX ( MacroGenics, Inc. ) opening price: $11.0000

Yesterday's MGNX ( MacroGenics, Inc. ) closing price: $10.9600

MacroGenics, Inc. Stock ( symbol: MGNX ) Price Chart since IPO (2013):

12 Months MacroGenics, Inc. Stock ( symbol: MGNX ) Price Chart

Popular Questions about MacroGenics, Inc. Public Stock ( MGNX )

A: MacroGenics, Inc. stock symbol (also called stock or share ticker) is MGNX

A: MacroGenics, Inc. IPO (Initial Public Offering) took place on 2013

A: MacroGenics, Inc.'s stock (MGNX symbol) price at ther IPO (initial Public Offering) was $11.0000

Q: Is MGNX stock worth buying at the moment?

A: The MGNX stock performance since 2019 are rather disappointing. If you had bought 1 share of MacroGenics, Inc. stock (symbol: MGNX) at the beginning of 2019, at the opening share price of $11.7300, you would be left with exactly $11.0000 - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy MacroGenics, Inc. Stock Easy Online

MacroGenics, Inc. Stock Ticker Price Chart since IPO:





MacroGenics, Inc. Stock Price Yesterday



 


MacroGenics, Inc. Stock Price – Last Week




 


MacroGenics, Inc. Stock Price – Last Month




 


MacroGenics, Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/11/1959336/0/en/MacroGenics-Presents-Results-from-the-SOPHIA-Study-of-Margetuximab-in-Patients-with-HER2-Positive-Metastatic-Breast-Cancer-at-the-San-Antonio-Breast-Cancer-Symposium.html
                            

                                
MacroGenics Presents Results from the SOPHIA Study of Margetuximab in Patients with HER2-Positive Metastatic Breast Cancer at the San Antonio Breast Cancer Symposium

                                
                                
Biologics License Application (BLA) submission to FDA expected befo...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/09/1958174/0/en/MacroGenics-Presents-Flotetuzumab-Data-in-Patients-with-Primary-Induction-Failure-and-Early-Relapsed-Acute-Myeloid-Leukemia-at-the-2019-ASH-Annual-Meeting.html
                            

                                
MacroGenics Presents Flotetuzumab Data in Patients with Primary Induction Failure and Early Relapsed Acute Myeloid Leukemia at the 2019 ASH Annual Meeting

                                
                                
Conference call scheduled for today at 8:00 p.m. ET Conference call...


                            

                        
                    

                


                            

                    


                        
                            https://247wallst.com/healthcare-business/2019/11/29/major-biopharma-catalysts-on-the-december-fda-calendar/
                            

                                
Major Biopharma Catalysts on the December FDA Calendar

                                
                                
Companies in the biotech and pharmaceutical industries are subject ...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4305289-macrogenics-inc-mgnx-ceo-scott-koenig-q3-2019-results-earnings-call-transcript
                            

                                
MacroGenics, Inc. (MGNX) CEO Scott Koenig on Q3 2019 Results - Earnings Call Transcript

                                
                                
MacroGenics, Inc. (MGNX) CEO Scott Koenig on Q3 2019 Results - Earn...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/607183/macrogenics-mgnx-reports-q3-loss-lags-revenue-estimates
                            

                                
MacroGenics (MGNX) Reports Q3 Loss, Lags Revenue Estimates

                                
                                
MacroGenics (MGNX) delivered earnings and revenue surprises of 4.21...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/06/1942287/0/en/MacroGenics-Announces-Flotetuzumab-Presentations-at-the-ASH-Annual-Meeting-2019.html
                            

                                
MacroGenics Announces Flotetuzumab Presentations at the ASH Annual Meeting 2019

                                
                                
ROCKVILLE, MD, Nov.  06, 2019  (GLOBE NEWSWIRE) --  MacroGenics, In...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/602463/3-medical-product-stocks-likely-to-beat-this-earnings-season
                            

                                
3 Medical Product Stocks Likely to Beat This Earnings Season

                                
                                
Despite the ongoing US-China trade war, solid growth in emerging ma...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/11/1959336/0/en/MacroGenics-Presents-Results-from-the-SOPHIA-Study-of-Margetuximab-in-Patients-with-HER2-Positive-Metastatic-Breast-Cancer-at-the-San-Antonio-Breast-Cancer-Symposium.html
                            

                                
MacroGenics Presents Results from the SOPHIA Study of Margetuximab in Patients with HER2-Positive Metastatic Breast Cancer at the San Antonio Breast Cancer Symposium

                                
                                
Biologics License Application (BLA) submission to FDA expected befo...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/09/1958174/0/en/MacroGenics-Presents-Flotetuzumab-Data-in-Patients-with-Primary-Induction-Failure-and-Early-Relapsed-Acute-Myeloid-Leukemia-at-the-2019-ASH-Annual-Meeting.html
                            

                                
MacroGenics Presents Flotetuzumab Data in Patients with Primary Induction Failure and Early Relapsed Acute Myeloid Leukemia at the 2019 ASH Annual Meeting

                                
                                
Conference call scheduled for today at 8:00 p.m. ET Conference call...


                            

                        
                    

                


                            

                    


                        
                            https://247wallst.com/healthcare-business/2019/11/29/major-biopharma-catalysts-on-the-december-fda-calendar/
                            

                                
Major Biopharma Catalysts on the December FDA Calendar

                                
                                
Companies in the biotech and pharmaceutical industries are subject ...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4305289-macrogenics-inc-mgnx-ceo-scott-koenig-q3-2019-results-earnings-call-transcript
                            

                                
MacroGenics, Inc. (MGNX) CEO Scott Koenig on Q3 2019 Results - Earnings Call Transcript

                                
                                
MacroGenics, Inc. (MGNX) CEO Scott Koenig on Q3 2019 Results - Earn...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/607183/macrogenics-mgnx-reports-q3-loss-lags-revenue-estimates
                            

                                
MacroGenics (MGNX) Reports Q3 Loss, Lags Revenue Estimates

                                
                                
MacroGenics (MGNX) delivered earnings and revenue surprises of 4.21...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/06/1942287/0/en/MacroGenics-Announces-Flotetuzumab-Presentations-at-the-ASH-Annual-Meeting-2019.html
                            

                                
MacroGenics Announces Flotetuzumab Presentations at the ASH Annual Meeting 2019

                                
                                
ROCKVILLE, MD, Nov.  06, 2019  (GLOBE NEWSWIRE) --  MacroGenics, In...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/602463/3-medical-product-stocks-likely-to-beat-this-earnings-season
                            

                                
3 Medical Product Stocks Likely to Beat This Earnings Season

                                
                                
Despite the ongoing US-China trade war, solid growth in emerging ma...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.